WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004035053) NEUROTROPHIC FACTOR PRODUCTION PROMOTER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/035053    International Application No.:    PCT/JP2003/013099
Publication Date: 29.04.2004 International Filing Date: 10.10.2003
IPC:
A61K 31/445 (2006.01), C07D 211/60 (2006.01)
Applicants: FUJISAWA PHARMACEUTICAL CO., LTD. [JP/JP]; 4-7, Doshomachi 3-chome, Chuo-ku, Osaka-shi, Osaka 541-8514 (JP) (For All Designated States Except US).
FURUKAWA, Shoei [JP/JP]; (JP) (For US Only).
NITTA, Atsumi [JP/JP]; (JP) (For US Only)
Inventors: FURUKAWA, Shoei; (JP).
NITTA, Atsumi; (JP)
Agent: TABUSHI, Eiji; Fujisawa Pharmaceutical Co., Ltd., Osaka Factory, 1-6, Kashima 2-chome, Yodogawa-ku, Osaka-shi, Osaka 532-8514 (JP)
Priority Data:
2002-300247 15.10.2002 JP
Title (EN) NEUROTROPHIC FACTOR PRODUCTION PROMOTER
(FR) PROMOTEUR DE PRODUCTION DU FACTEUR NEUROTROPHIQUE
(JA) 神経栄養因子産生促進剤
Abstract: front page image
(EN)It is intended to provide a neurotrophic factor production promoter which contains, as the active ingredient, N-acetyl-L-pipecolinic acid or its pharmaceutically acceptable salt and is usable in preventing or treating neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, spinal injury, Huntington’s disease, brain infarction, cranial trauma, multiple sclerosis, amyotrophic lateral sclerosis, diabetic or drug-induced peripheral neuropathy and retinal neuropathy.
(FR)L'invention concerne un promoteur de production du facteur neurotrophique qui contient, comme principe actif, l'acide N-acétyle-L-pipecolinique ou son sel pharmaceutiquement acceptable, et que l'on peut utiliser au niveau de la prévention ou du traitement de maladies neurodégénératives telles que les maladies d'Alzheimer et de Parkinson, des lésions médullaires, la maladie de Huntington, l'infarctus cérébral, le traumatisme crânien, la sclérose en plaques, la sclérose latérale amyotrophique, la neuropathie diabétique, la neuropathie périphérique induite par des médicaments et la neuropathie rétinienne.
(JA)N-アセチル-L-ピペコリン酸またはその医薬として許容される塩を有効成分として含有する、アルツハイマー病、パーキンソン病、脊髄損傷、ハンチントン病、脳梗塞、頭部外傷、多発性硬化症、筋萎縮性側索硬化症、糖尿病性あるいは薬物誘発性の末梢神経障害、網膜神経障害等の神経変性疾患の予防または治療に用いうる新規な神経栄養因子産生促進剤を提供する。
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)